Clinical Significance of Protein Expression of Cyclooxygenase-2 and Somatostatin Receptors in Gastroenteropancreatic Neuroendocrine Tumors
Hee Sung Kim, Hye Seung Lee, Woo Ho Kim
Cancer Res Treat. 2011;43(3):181-188.   Published online 2011 Sep 30     DOI: https://doi.org/10.4143/crt.2011.43.3.181
Citations to this article as recorded by Crossref logo
Gastroenteropancreatic neuroendocrine neoplasms and inflammation: A complex cross-talk with relevant clinical implications
Giovanni Vitale, Silvia Carra, Francesco Ferraù, Elia Guadagno, Antongiulio Faggiano, Annamaria Colao
Critical Reviews in Oncology/Hematology.2020; 146: 102840.     CrossRef
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?
Giovanni Vitale, Alessandra Dicitore, Luigi Barrea, Emilia Sbardella, Paola Razzore, Severo Campione, Antongiulio Faggiano, Annamaria Colao, Manuela Albertelli, Barbara Altieri, Filomena Bottiglieri, Federica De Cicco, Sergio Di Molfetta, Giuseppe Fanciul
Reviews in Endocrine and Metabolic Disorders.2020;[Epub]     CrossRef
Comparative study of four different types of intraperitoneal mesh prostheses in rats
Rogério Aoki Fuziy, Ricardo Artigiani Neto, Elesiario Marques Caetano Junior, Ana Karina Soares Alves, Gaspar Jesus Lopes Filho, Marcelo Moura Linhares
Acta Cirurgica Brasileira.2019;[Epub]     CrossRef
Clinical and Prognostic Value of PET/CT Imaging with Combination of 68Ga-DOTATATE and 18F-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms
Panpan Zhang, Jiangyuan Yu, Jie Li, Lin Shen, Nan Li, Hua Zhu, Shizhen Zhai, Yan Zhang, Zhi Yang, Ming Lu
Contrast Media & Molecular Imaging.2018; 2018: 1.     CrossRef
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene
Valentina Indio, Annalisa Astolfi, Giuseppe Tarantino, Milena Urbini, Janice Patterson, Margherita Nannini, Maristella Saponara, Lidia Gatto, Donatella Santini, Italo do Valle, Gastone Castellani, Daniel Remondini, Michelangelo Fiorentino, Margaret von Me
International Journal of Molecular Sciences.2018; 19(3): 732.     CrossRef
Pasireotide in the treatment of neuroendocrine tumors: a review of the literature
Giovanni Vitale, Alessandra Dicitore, Concetta Sciammarella, Sergio Di Molfetta, Manila Rubino, Antongiulio Faggiano, Annamaria Colao
Endocrine-Related Cancer.2018; 25(6): R351.     CrossRef
Cyclooxygenase-2 up-regulates hepatic somatostatin receptor 2 expression
Yao-Yao Lu, Jin-Hang Gao, Chong Zhao, Shi-Lei Wen, Cheng-Wei Tang, Yu-Fang Wang
Scientific Reports.2018;[Epub]     CrossRef
177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours
Emre Demirci, Levent Kabasakal, Turkay Toklu, Meltem Ocak, Onur E. Şahin, Nalan Alan-Selcuk, Ahmet Araman
Nuclear Medicine Communications.2018; 39(8): 789.     CrossRef
Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome
Romain Appay, Emeline Tabouret, Mehdi Touat, Catherine Carpentier, Carole Colin, François Ducray, Ahmed Idbaih, Karima Mokhtari, Emmanuelle Uro-Coste, Caroline Dehais, Dominique Figarella-Branger
Acta Neuropathologica Communications.2018;[Epub]     CrossRef
Prognostic and predictive biomarkers for somatostatin analogs, peptide receptor radionuclide therapy and serotonin pathway targets in neuroendocrine tumours
Jorge Barriuso, Ana Custodio, Ruth Afonso, Vicente Alonso, Aurora Astudillo, Jaume Capdevila, Rocío García-Carbonero, Enrique Grande, Paula Jimenez-Fonseca, Mónica Marazuela, Cristina Rodríguez-Antona, Javier Aller
Cancer Treatment Reviews.2018; 70: 209.     CrossRef
The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors
Philippe Brunner, Ann-Catherine Jörg, Katharina Glatz, Lukas Bubendorf, Piotr Radojewski, Maria Umlauft, Nicolas Marincek, Petar-Marko Spanjol, Thomas Krause, Rebecca A. Dumont, Helmut R. Maecke, Jan Müller-Brand, Matthias Briel, Anja Schmitt, Aurel Perre
European Journal of Nuclear Medicine and Molecular Imaging.2017; 44(3): 468.     CrossRef
Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors
G. Lamberti, C. Ceccarelli, N. Brighi, I. Maggio, D. Santini, C. Mosconi, C. Ricci, G. Biasco, D. Campana
Gastroenterology Research and Practice.2017; 2017: 1.     CrossRef
The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review
Michael Michael, Rocio Garcia‐Carbonero, Matthias M. Weber, Catherine Lombard‐Bohas, Christos Toumpanakis, Rodney J. Hicks
The Oncologist.2017; 22(3): 272.     CrossRef
Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors
Ki Byung Song, Song Cheol Kim, Ji Hun Kim, Dong-Wan Seo, Seung-Mo Hong, Kwang-Min Park, Dae Wook Hwang, Jae Hoon Lee, Young-Joo Lee
Pancreas.2016; 45(2): 187.     CrossRef
Small Cell Carcinomas of the Bladder Highly Express Somatostatin Receptor Type 2A
Nalan Neşe, Banu S. Kumbaraci, Dilek E. Baydar, Işin Kiliçaslan, Ayşegül A. Sari, Sait Şen, Ipek I. Gönül, Duygu Kankaya, Yasemin Özlük, Murat Ermete, Ayşim Özağari, Nebil Bal, Saba Kiremitçi, Kürşat Yildiz, Burçin Tuna, Nilay Şen, Kutsal Yörükoğlu
Applied Immunohistochemistry & Molecular Morphology.2016; 24(4): 253.     CrossRef
Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts
Joo Young Kim, Seung-Mo Hong
Archives of Pathology & Laboratory Medicine.2016; 140(5): 437.     CrossRef
Algorithmic approach to neuroendocrine tumors in targeted biopsies: Practical applications of immunohistochemical markers
Kai Duan, Ozgur Mete
Cancer Cytopathology.2016; 124(12): 871.     CrossRef
Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors
Zhi Rong Qian, Tingting Li, Monica Ter-Minassian, Juhong Yang, Jennifer A. Chan, Lauren K. Brais, Yohei Masugi, Arunthathi Thiaglingam, Nichole Brooks, Reiko Nishihara, Mireille Bonnemarie, Atsuhiro Masuda, Kentaro Inamura, Sun A. Kim, Kosuke Mima, Yasuta
Pancreas.2016; 45(10): 1386.     CrossRef
GROWTH FACTORS AND COX2 IN WOUND HEALING: AN EXPERIMENTAL STUDY WITH EHRLICH TUMORS
Flávio L. L. SALGADO, Ricardo ARTIGIANI-NETO, Gaspar de Jesus LOPES-FILHO
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo).2016; 29(4): 223.     CrossRef
Down-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin
Guisheng Zhou, Jim Sinnett-Smith, Shi-He Liu, Juehua Yu, James Wu, Robbi Sanchez, Stephen J. Pandol, Ravinder Abrol, John Nemunaitis, Enrique Rozengurt, F. Charles Brunicardi
Frontiers in Physiology.2014;[Epub]     CrossRef
An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes
D J Pinato, T M Tan, S T K Toussi, R Ramachandran, N Martin, K Meeran, N Ngo, R Dina, R Sharma
British Journal of Cancer.2014; 110(1): 115.     CrossRef
Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor
Punit Sharma, Niraj Naswa, Sudhir Suman KC, Luis Andres Alvarado, Alok Kumar Dwivedi, Yashwant Yadav, Rakesh Kumar, Ariachery C. Ammini, Chandrasekhar Bal
European Journal of Nuclear Medicine and Molecular Imaging.2014; 41(12): 2194.     CrossRef
Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures
A. Mohamed, M.-P. Blanchard, M. Albertelli, F. Barbieri, T. Brue, P. Niccoli, J.-R. Delpero, G. Monges, S. Garcia, D. Ferone, T. Florio, A. Enjalbert, V. Moutardier, A. Schonbrunn, C. Gerard, A. Barlier, A. Saveanu
Endocrine Related Cancer.2014; 21(5): 691.     CrossRef